Orexigen Therapeutics, Inc. (NASDAQ:OREX)
CAPS Rating:
A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.
RSS Headlines
Fool UK